1. Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first‐relapse/primary refractory diffuse large B‐cell lymphoma. (25th March 2014) Authors: Feldman, Tatyana; Mato, Anthony R.; Chow, Kar F.; Protomastro, Ewelina A.; Yannotti, Kara M. L.; Bhattacharyya, Pritish; Yang, Xiao; Donato, Michele L.; Rowley, Scott D.; Carini, Carolanne; Valentinetti, Marisa; Smith, Judith; Gadaleta, Gabriella; Bejot, Coleen; Stives, Susan; Timberg, Mary; Kdir... Journal: British journal of haematology Issue: Volume 166:Number 1(2014:Jul.) Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Reduced‐dose fludarabine, cyclophosphamide, and rituximab (FCR‐Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia. Issue 6 (30th March 2015) Authors: Mato, Anthony R.; Foon, Kenneth A.; Feldman, Tatyana; Schuster, Stephen J.; Svoboda, Jakub; Chow, Kar Fai; Valentinetti, Marisa; Mrkulic, Mary; Azzollini, Kelly; Gadaleta, Gabriella; Bhattacharyya, Pritish K.; Zenreich, Joshua; Pascual, Lauren‐Nicole; Yannotti, Kara; Kdiry, Sabrina; Howlett, Chri... Journal: American journal of hematology Issue: Volume 90:Issue 6(2015:Jun.) Page Start: 487 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Targeting indolent non-Hodgkin lymphoma. Issue 4 (3rd April 2017) Authors: Leslie, Lori A.; Skarbnik, Alan P.; Bejot, Coleen; Stives, Susan; Feldman, Tatyana A.; Goy, Andre H. Journal: Expert review of hematology Issue: Volume 10:Issue 4(2017) Page Start: 299 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗